Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 68382-396
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 68382-396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2 (E99193a4 96eb 4950 Af3c B3acc42dae59 02)
Vial-label (E99193a4 96eb 4950 Af3c B3acc42dae59 03)
Sodium Phenylacetate and Sodium Benzoate Injection is a sterile, concentrated solution that must be diluted with sterile, dextrose injection before intravenous administration for intravenous use only. The lot number and expiration date are provided on the packaging, and the single-dose vial contains 100 mg of sodium phenylacetate and 100 g of Sodium benzoate, along with water for injection. It is important to administer the injection through a central line to avoid causing burns. This product is distributed by Zydus Pharmaceuticals USA Inc. and must be stored at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). The dosage information is provided in the accompanying insert.*
Carton-label (E99193a4 96eb 4950 Af3c B3acc42dae59 04)
This is a description of a medication with the NDC code 68382-396-01, which is for Rx Only use. The medication is called Sodium Phenylacetate and Sodium Benzoate Injection and comes in a 50mL container. The medication is for intravenous use only and must be diluted before administration with sterile, dextrose injection, 10% (D10W). Each mL of the medication contains 100 mg of sodium phenylacetate and 100 mg of sodium benzoate along with water for injection. The medication's pH may have been adjusted with sodium hydroxide or hydrochloric acid. The dosage information can be found in the accompanying package insert. The medication should be stored at 25°C (77°F), with permitted excursions to 15°-30°C (59°-86°F), and should be kept out of reach of children. Zydus Pharmaceuticals USA Inc. distributes the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.